{"transactions":[{"id":764739,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T23:45:09.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":220000,"derivative":{"exercise_price":1.26,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001553389-26-000002","document":"form4-05262026_070505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000155338926000002/form4-05262026_070505.xml","form_type":"4"}},{"id":1138188,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:02:43.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":180000,"derivative":{"exercise_price":1.34,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000886744-25-000023","document":"wk-form4_1747947757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000023/wk-form4_1747947757.xml","form_type":"4"}},{"id":1473302,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:35:15.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":3.8,"expiration_date":"2034-06-16","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001415889-24-017657","document":"form4-06202024_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000141588924017657/form4-06202024_040611.xml","form_type":"4"}},{"id":1521317,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-10T20:05:15.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":180000,"derivative":{"exercise_price":3.88,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000950170-24-057798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024057798/ownership.xml","form_type":"4"}},{"id":1694772,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T00:04:09.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":6220,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on closing price of the Issuer's Common Stock on December 29, 2023 of $2.11 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on closing price of the Issuer's Common Stock on December 29, 2023 of $2.11 per share."}],"balance_after":130527,"source":{"system":"sec-edgar","filing":"0001209191-24-000546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000120919124000546/doc4.xml","form_type":"4"}},{"id":1770916,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-02T23:32:16.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":6191,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on closing price of Geron Common Stock on September 29, 2023 of $2.12 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on closing price of Geron Common Stock on September 29, 2023 of $2.12 per share."}],"balance_after":124307,"source":{"system":"sec-edgar","filing":"0001062993-23-018726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323018726/form4.xml","form_type":"4"}},{"id":1841479,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-01T01:19:53.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":4088,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for annual board of directors retainer fee. Number of shares issued based on close price of Geron Common stock on June 30, 2023 of $3.21 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for annual board of directors retainer fee. Number of shares issued based on close price of Geron Common stock on June 30, 2023 of $3.21 per share."}],"balance_after":118116,"source":{"system":"sec-edgar","filing":"0001062993-23-014272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323014272/form4.xml","form_type":"4"}},{"id":1858937,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:26:44.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":76200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3rd) of the shares subject to the option shall vest on June 8, 2024, and one twenty-fourth (1/24th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":76200,"derivative":{"exercise_price":11.66,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":76200},"source":{"system":"sec-edgar","filing":"0001209191-23-036313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919123036313/doc4.xml","form_type":"4"}},{"id":1870943,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T23:34:36.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":125000,"derivative":{"exercise_price":3.27,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001062993-23-012819","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323012819/form4.xml","form_type":"4"}},{"id":1910690,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-05-02T01:20:33.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.1,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-009883","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323009883/form4.xml","form_type":"4"}},{"id":1910689,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T01:20:33.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":35000,"price":2.48,"value":86800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-009883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323009883/form4.xml","form_type":"4"}},{"id":1910688,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T01:20:33.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":1.1,"value":38500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 17, 2023."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001062993-23-009883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323009883/form4.xml","form_type":"4"}},{"id":1933203,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T00:47:32.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":6048,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for annual board of directors retainer fee. Number of shares issued based on close price of Geron Common stock on March 31, 2023 of $2.17 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for annual board of directors retainer fee. Number of shares issued based on close price of Geron Common stock on March 31, 2023 of $2.17 per share."}],"balance_after":114028,"source":{"system":"sec-edgar","filing":"0001062993-23-008380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323008380/form4.xml","form_type":"4"}},{"id":2028427,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T16:44:10.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in full on February 3, 2024, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date."}],"balance_after":14150,"derivative":{"exercise_price":1.69,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001209191-23-007547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662244/000120919123007547/doc4.xml","form_type":"4"}},{"id":2046371,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2023-01-25T16:00:17.000Z","date":"2023-01-23","kind":"tax_withholding","acquired":false,"shares":526,"price":0.4461,"value":234.6486,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by the Molineaux Family Trust of which the Reporting Person is a Trustee."}],"balance_after":27859,"source":{"system":"sec-edgar","filing":"0000899243-23-002610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924323002610/doc4.xml","form_type":"4"}},{"id":2275415,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T22:17:08.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":125000,"derivative":{"exercise_price":1.48,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001062993-22-012157","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299322012157/form4.xml","form_type":"4"}},{"id":2374762,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T17:01:17.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in full on February 22, 2023, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date."}],"balance_after":14150,"derivative":{"exercise_price":5.96,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000899243-22-007650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662244/000089924322007650/doc4.xml","form_type":"4"}},{"id":2424004,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-27T18:41:13.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":597475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 25, 2022; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":597475,"derivative":{"exercise_price":0.44,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":597475},"source":{"system":"sec-edgar","filing":"0000899243-22-003487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924322003487/doc4.xml","form_type":"4"}},{"id":2517777,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2021-11-10T19:34:28.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":100000,"price":0.8467,"value":84670.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8152 to $0.8791, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Molineaux Family Trust of which the Reporting Person is a Trustee."}],"balance_after":557188,"source":{"system":"sec-edgar","filing":"0000899243-21-044154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321044154/doc4.xml","form_type":"4"}},{"id":2715354,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T01:20:47.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":83000,"derivative":{"exercise_price":1.39,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0000886744-21-000036","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674421000036/edgar.xml","form_type":"4"}},{"id":2735542,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-04-29T22:13:48.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-21-004701","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911021004701/edgar.xml","form_type":"4"}},{"id":2735541,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-29T22:13:48.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":9828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9828,"source":{"system":"sec-edgar","filing":"0001179110-21-004701","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911021004701/edgar.xml","form_type":"4"}},{"id":2899251,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-22T20:37:11.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth (1/4th) of the Option vests one year after January 20, 2021; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":375000,"derivative":{"exercise_price":2.98,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0000899243-21-003050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003050/doc4.xml","form_type":"4"}},{"id":2899250,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2021-01-22T20:37:11.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest as follows: one-fourth (1/4th) of the shares subject to the Restricted Stock Unit will vest each year after January 20, 2021 until the Restricted Stock Units are fully vested.  The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares acquired on each of December 10, 2019, June 10, 2020, and December 10, 2020 under the Company's 2014 Employee Stock Purchase Plan."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0000899243-21-003050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321003050/doc4.xml","form_type":"4"}},{"id":3117579,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-09T22:13:22.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":83000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0000886744-20-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674420000050/edgar.xml","form_type":"4"}},{"id":3166269,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-04-30T23:56:32.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-20-005320","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911020005320/edgar.xml","form_type":"4"}},{"id":3166268,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-04-30T23:56:32.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6635,"source":{"system":"sec-edgar","filing":"0001179110-20-005320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911020005320/edgar.xml","form_type":"4"}},{"id":3305274,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-22T18:17:18.000Z","date":"2020-01-18","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":400000,"derivative":{"exercise_price":7.41,"expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-20-001696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924320001696/doc4.xml","form_type":"4"}},{"id":3476877,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-06-27T16:05:51.000Z","date":"2019-06-25","kind":"purchase","acquired":true,"shares":51600,"price":3.88,"value":200208.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.8278 to $3.8938. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 5,000 shares transferred from the Reporting Person and 5,000 shares transferred from the Reporting Person's spouse, to the Molineaux Family Trust on March 27, 2019."}],"balance_after":457188,"source":{"system":"sec-edgar","filing":"0000899243-19-018344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319018344/doc4.xml","form_type":"4"}},{"id":3497988,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T23:24:00.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":70000,"derivative":{"exercise_price":1.38,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000886744-19-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674419000063/edgar.xml","form_type":"4"}},{"id":3541963,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T22:44:41.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005477","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911019005477/edgar.xml","form_type":"4"}},{"id":3541962,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T22:44:41.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8385,"source":{"system":"sec-edgar","filing":"0001179110-19-005477","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911019005477/edgar.xml","form_type":"4"}},{"id":3665902,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-02-11T16:05:33.000Z","date":"2019-02-07","kind":"gift","acquired":false,"shares":12986,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares transferred to the Reporting Person's children.  The securities owned by the children are not beneficially owned by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee"}],"balance_after":395588,"source":{"system":"sec-edgar","filing":"0000899243-19-003138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319003138/doc4.xml","form_type":"4"}},{"id":3696429,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-14T16:33:57.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 10, 2019; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":390000,"derivative":{"exercise_price":4.64,"expiration_date":"2029-01-09","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0000899243-19-001133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319001133/doc4.xml","form_type":"4"}},{"id":3715047,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T00:23:27.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 31, 2018 of $1.00 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 31, 2018 of $1.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 31, 2018 of $1.00 per share."}],"balance_after":107980,"source":{"system":"sec-edgar","filing":"0000886744-19-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674419000005/edgar.xml","form_type":"4"}},{"id":3760974,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2018-11-16T16:07:06.000Z","date":"2018-11-14","kind":"gift","acquired":false,"shares":6476,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares transferred to the Reporting Person's children.  The securities owned by the children are not beneficially owned by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 44,860 shares transferred from the Reporting Person to the Trust on April 10, 2018."}],"balance_after":408574,"source":{"system":"sec-edgar","filing":"0000899243-18-029127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318029127/doc4.xml","form_type":"4"}},{"id":3806139,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-29T00:03:02.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 28, 2018 of $1.76 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 28, 2018 of $1.76 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 28, 2018 of $1.76 per share."}],"balance_after":94855,"source":{"system":"sec-edgar","filing":"0000886744-18-000053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000053/edgar.xml","form_type":"4"}},{"id":3879500,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-02T22:37:28.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":3827,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 29, 2018 of $3.43 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 29, 2018 of $3.43 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 29, 2018 of $3.43 per share."}],"balance_after":87398,"source":{"system":"sec-edgar","filing":"0000886744-18-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000041/edgar.xml","form_type":"4"}},{"id":3929297,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T20:48:23.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates."}],"balance_after":70000,"derivative":{"exercise_price":3.43,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000886744-18-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000035/edgar.xml","form_type":"4"}},{"id":3946881,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T22:16:29.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911018006192/edgar.xml","form_type":"4"}},{"id":3946880,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T22:16:29.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14186,"source":{"system":"sec-edgar","filing":"0001179110-18-006192","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911018006192/edgar.xml","form_type":"4"}},{"id":3978947,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-30T22:06:46.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":3088,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 29, 2018 of $4.25 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 29, 2018 of $4.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 29, 2018 of $4.25 per share."}],"balance_after":83571,"source":{"system":"sec-edgar","filing":"0000886744-18-000023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000023/edgar.xml","form_type":"4"}},{"id":4011125,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-06T16:12:07.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":6798,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":6798},"source":{"system":"sec-edgar","filing":"0000899243-18-006476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318006476/doc4.xml","form_type":"4"}},{"id":4011124,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-06T16:12:07.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":26992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":9729,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":26992},"source":{"system":"sec-edgar","filing":"0000899243-18-006476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318006476/doc4.xml","form_type":"4"}},{"id":4011123,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2018-03-06T16:12:07.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":26992,"price":2.64,"value":71258.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017."}],"balance_after":44860,"source":{"system":"sec-edgar","filing":"0000899243-18-006476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318006476/doc4.xml","form_type":"4"}},{"id":4099356,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-16T16:05:46.000Z","date":"2018-01-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after January 11, 2018; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":200000,"derivative":{"exercise_price":8.6,"expiration_date":"2028-01-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-18-001072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318001072/doc4.xml","form_type":"4"}},{"id":4118127,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-02T23:21:19.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":7292,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 29, 2017 of $1.80 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 29, 2017 of $1.80 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 29, 2017 of $1.80 per share."}],"balance_after":80483,"source":{"system":"sec-edgar","filing":"0000886744-18-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000002/edgar.xml","form_type":"4"}},{"id":4140416,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":6006,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4140415,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":6502,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 05/23/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":0,"derivative":{"exercise_price":0.96,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":6502},"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4140414,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":34030,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4140413,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":7568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 05/23/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":0,"derivative":{"exercise_price":0.96,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":7568},"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4140412,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":true,"shares":5300,"price":2.64,"value":13992.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017."}],"balance_after":15368,"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4140411,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2017-12-06T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":true,"shares":7568,"price":0.96,"value":7265.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017."}],"balance_after":10068,"source":{"system":"sec-edgar","filing":"0000899243-17-028063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317028063/doc4.xml","form_type":"4"}},{"id":4198367,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T21:32:49.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":6021,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 29, 2017 of $2.18 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 29, 2017 of $2.18 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 29, 2017 of $2.18 per share."}],"balance_after":73191,"source":{"system":"sec-edgar","filing":"0000886744-17-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000042/edgar.xml","form_type":"4"}},{"id":4269655,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T23:48:42.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":4738,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 30, 2017 of $2.77 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 30, 2017 of $2.77 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on June 30, 2017 of $2.77 per share."}],"balance_after":67170,"source":{"system":"sec-edgar","filing":"0000886744-17-000036","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000036/edgar.xml","form_type":"4"}},{"id":4313146,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T22:04:42.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001179110-17-007543","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553389/000117911017007543/edgar.xml","form_type":"4"}},{"id":4327209,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-11T00:52:42.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates."}],"balance_after":50000,"derivative":{"exercise_price":2.63,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000886744-17-000030","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000030/edgar.xml","form_type":"4"}},{"id":4367527,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-31T23:28:32.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":5782,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 31, 2017 of $2.27 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 31, 2017 of $2.27 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on March 31, 2017 of $2.27 per share."}],"balance_after":62432,"source":{"system":"sec-edgar","filing":"0000886744-17-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000017/edgar.xml","form_type":"4"}},{"id":4508809,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T00:56:46.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":6341,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 30, 2016 of $2.07 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 30, 2016 of $2.07 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on December 30, 2016 of $2.07 per share."}],"balance_after":56650,"source":{"system":"sec-edgar","filing":"0000886744-17-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000002/edgar.xml","form_type":"4"}},{"id":4515433,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":4749,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":9498,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":4749},"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4515432,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":5418,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 05/23/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":6502,"derivative":{"exercise_price":0.96,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":5418},"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4515431,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":15627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments one month from 12/17/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":42021,"derivative":{"exercise_price":2.64,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":15627},"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4515430,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":6306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the Option vests in equal monthly installments one month from 05/23/2013.  The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":7568,"derivative":{"exercise_price":0.96,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":6306},"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4515429,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":true,"shares":15627,"price":2.64,"value":41255.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes1,877 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016."}],"balance_after":23810,"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4515428,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2016-12-20T09:00:29.000Z","date":"2016-12-19","kind":"exercise","acquired":true,"shares":6306,"price":0.96,"value":6053.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes1,877 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016."}],"balance_after":8183,"source":{"system":"sec-edgar","filing":"0000899243-16-036013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316036013/doc4.xml","form_type":"4"}},{"id":4537152,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-01T16:05:21.000Z","date":"2016-11-29","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the Option vests one year after November 29, 2016; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter.  The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company."}],"balance_after":165000,"derivative":{"exercise_price":3.35,"expiration_date":"2026-11-28","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0000899243-16-034658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924316034658/doc4.xml","form_type":"4"}},{"id":4590930,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":44452,"kind":"person","name":"Molineaux Susan","position":1,"cik":"0001553389","reported_name":"Molineaux Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T22:59:22.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":5808,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 30, 2016 of $2.26 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 30, 2016 of $2.26 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of cash payment for quarterly board of directors retainer fee. Number of shares issued based on close price on September 30, 2016 of $2.26 per share."}],"balance_after":50309,"source":{"system":"sec-edgar","filing":"0000886744-16-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674416000071/edgar.xml","form_type":"4"}}]}